Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regen BioPharma (RGBPP) Return on Equity (2016 - 2025)

Historic Return on Equity for Regen BioPharma (RGBPP) over the last 12 years, with Q4 2025 value amounting to 0.12%.

  • Regen BioPharma's Return on Equity fell 700.0% to 0.12% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.12%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.22% for FY2025, which is 900.0% up from last year.
  • According to the latest figures from Q4 2025, Regen BioPharma's Return on Equity is 0.12%, which was down 700.0% from 0.21% recorded in Q3 2025.
  • In the past 5 years, Regen BioPharma's Return on Equity ranged from a high of 0.21% in Q3 2025 and a low of 0.01% during Q1 2022
  • Moreover, its 5-year median value for Return on Equity was 0.1% (2024), whereas its average is 0.1%.
  • As far as peak fluctuations go, Regen BioPharma's Return on Equity surged by 1500bps in 2023, and later tumbled by -800bps in 2024.
  • Regen BioPharma's Return on Equity (Quarter) stood at 0.04% in 2021, then soared by 233bps to 0.13% in 2022, then tumbled by -38bps to 0.08% in 2023, then soared by 141bps to 0.19% in 2024, then tumbled by -38bps to 0.12% in 2025.
  • Its Return on Equity was 0.12% in Q4 2025, compared to 0.21% in Q3 2025 and 0.17% in Q2 2025.